The following abstracts and posters were curated from all the posters presented at a recent gastroenterology congress held in Washington, DC. The central themes of these posters are drug safety, preventing disease recurrence, and switching among treatments. Specifically, the posters we selected highlight the incidence of serious infections and the efficacy associated with biologic agents and other immunomodulating therapies among patients with Crohn's disease and ulcerative colitis.

Faculty

Target Audience

National audience of gastroenterologists, primary care physicians, and other health care providers who manage patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).

Learning Objectives

At the conclusion of this activity, participants should be better able to:

• Summarize the latest research developments in the management of Crohn's disease and ulcerative colitis
• Incorporate evidence-based research into clinical practice

Instructions

You may participate by listening to any–or all–of the audio discussions. Click the 'Play' button to hear our faculty review the data and clinical implications of each poster/abstract. Two questions will appear at the end of each discussion. When ready to claim your CE/CME credit, complete the "Program Evaluation" and then click on the "Certificate" button to download your certificate

This activity is supported by an independent educational grant from AbbVie and Allergan, Inc.